Significant Up-regulation of Mir-17 in an Alzheimer’s Disease Mouse Model by Dalton, Matthew et al.
Liberty University
DigitalCommons@Liberty
University
Other Undergraduate Scholarship Department of Biology and Chemistry
6-2015
Significant Up-regulation of Mir-17 in an
Alzheimer’s Disease Mouse Model
Matthew Dalton
mdalton15@liberty.edu
Amanda Hazy
Gary D. Isaacs
Follow this and additional works at: http://digitalcommons.liberty.edu/bio_undergrad_schol
This Presentation is brought to you for free and open access by the Department of Biology and Chemistry at DigitalCommons@Liberty University. It
has been accepted for inclusion in Other Undergraduate Scholarship by an authorized administrator of DigitalCommons@Liberty University. For
more information, please contact scholarlycommunication@liberty.edu.
Recommended Citation
Dalton, Matthew; Hazy, Amanda; and Isaacs, Gary D., "Significant Up-regulation of Mir-17 in an Alzheimer’s Disease Mouse Model"
(2015). Other Undergraduate Scholarship. Paper 2.
http://digitalcommons.liberty.edu/bio_undergrad_schol/2
Significant Up-regulation of Mir-17 in an Alzheimer’s Disease 
Mouse Model
Matthew Dalton, Amanda Házy, and Gary D. Isaacs
Department of Biology and Chemistry, Liberty University, Lynchburg, VA 24515
In Vivo AD Mouse Model
Two transgenes (APP, PSEN1)Healthy Control
•APP and PSEN1 transgenic mice (Jackson Lab).
•Isolate RNA from mouse brain and blood samples (n=3).
•Determine the differential expression levels of miRNA. 
Gene Expression, AD, and Epigenetics
• AD development does not follow typical 
Mendelian inheritance patters.
• In fact, lines of evidence suggests that AD 
development is tied to epigenetic modifications.
• Previous work by our group has identified 
epigenetic changes in the AD brain.
• Several genes encoding micro RNA (miRNA) 
were identified to have epigenetic modifications, 
particularly changes to methylation status.
Micro RNA Overview
miR-17-92 Cluster
miRNA Investigation Criteria
• Previous research by our group revealed 
epigenetic modification of genes that code for 
miRNA, including some members of the miR-17-
92 cluster.
• Investigation criteria of miRNA was based on 
those which exhibited epigenetic modifications.
Evaluation of miR-17 Targets
• miR-17 has been shown to target Beclin-1 directly, 
downregulating its expression in other tissues.
• Additionally, dysregulation of Beclin-1 has been shown 
to modulate amyloid beta accumulation in mice.
• This could indicate a possible epigenetic basis for 
amyloid beta deposits in the AD brain. 
Looking Forward
• Identification of other dysregulated miRNA that also 
display epigenetic modifications.
• Future studies will investigate the validity of miR-17 
targeting Beclin-1 in the hippocampus of mice and if its 
dysregulation results in amyloid beta accumulation in 
our model.
• miR-17: passenger or molecular driver of AD pathology?
• Potential for Anti-miR AD therapy.
• miRNA are small (~22nt) non-coding RNA.
• These RNAs function as post-transcriptional regulators 
of various protein-coding genes.
• miRNAs are estimated to be responsible for regulating 
over 1/3 of the mammalian genome.
• Since their discovery in 1993, miRNA have been 
shown to be key regulatory elements in various 
fundamental biological processes, including apoptosis.
• miR-17-92 is a polycistronic miRNA cluster.
• This cluster is among the best-studied miRNA
clusters and has gained an incredible amount of 
attention over the past 3 years.
• Dysregulation of this cluster has been shown to 
be involved in a variety of pathologies, including 
tumorigenesis and neurodegeneration.
Total RNA isolated from the 
hippocampus of AD and 
control mice.
miScript primer assay 
(Qiagen) was used to 
determine relative 
expression of miRNA.
Differential expression
analyzed based on fold 
change. 
miRNA were polyadenylated
and an miRNA-specific 
universal tag was added via 
5’ end of Oligo-dT primer. 
miRNA Expression Analysis
Differential miRNA Expression
• Expression changes analyzed in mir-17, mir-26b, mir-
92, and mir-702.
• GAPDH and Tubb3 were used to normalize 
expression data.
• Of those analyzed, miR-17 displayed consistent up-
regulation in all AD mice when compared to controls.
• Results identify a novel association between miR-17 
and AD.
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